Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04916938
Other study ID # APHP180615
Secondary ID ID-RCB Number
Status Recruiting
Phase N/A
First received
Last updated
Start date December 29, 2021
Est. completion date December 2024

Study information

Verified date October 2022
Source Assistance Publique - Hôpitaux de Paris
Contact Bérengère BEAUQUIER-MACCOTTA, MD
Phone +33 6 62 17 62 92
Email b.beauquier@epsve.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to assess if an early therapeutic management focused on the mother-baby interaction using Interaction Guidance Therapy (IGT) with video feedback, brings an improvement of the maternal sensitivity in the interaction but also a decrease of the post-traumatic maternal symptoms. Post Natal Post traumatic stress is known as a disorder that impaired maternal mental health but also development of motherhood and the construction of the bond to the baby through interactive disturbances. The investigators will screen, among women who had a traumatic perception of an event related to the pregnancy or the childbirth, those who still present posttraumatic stress symptoms at 4 weeks post-partum. Four weeks from the traumatic event is the minimum delay to qualify a PTSD. After randomization IGT versus Treatment As Usual (TAU), the investigators planned an early therapeutic intervention, 3 sessions at 8, 10 and 12 weeks of post-partum. The investigators will assess the effect of the IGT on Maternal sensitivity and on the intensity of post-traumatic stress symptoms at 3 month post-partum and 1year.


Description:

The investigators will compare the efficacy of Interactive Guidance Therapy, a parent-infant psychotherapy using video feed back versus a dyadic treatment conduct as usual (TAU) in women who present a post traumatic stress disorder related to childbirth or pregnancy. The main assessment is the maternal sensitivity, assessed during a video recorded free play interaction between the mother and the baby and rate with the Coding of interactive Behaviour (CIB). This is a Single Blind Randomized clinical trial. Only the rating of the (CIB), which is the primary end point, will be done blind for the treatment the dyad received. The randomization will proceed after the inclusion visit and the first assessment that take place at 6 weeks of post partum. The following assessments will take place at 4 months and 12 months. The investigators will conduct a national multicentre study with 5 inclusions centres, which are all child psychiatry unit specialized in perinatal period and already train or in training for the IGT method. - Pre-screening in post partum ward or during post partum consultation. - Pre Inclusion at 5 (+-1) weeks to assess PTSD with Post traumatic checklist (PCL -5) - Inclusion and First assessment at 6 weeks post partum - Randomization: 3 session of IGT or TAU at 8 weeks, 10 weeks and 12 weeks Assessment at 4 months (+/-2W) and 12 months (+/- 1M)


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date December 2024
Est. primary completion date April 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: For the mother: 1. Mother over 18 years old, who gave birth to a healthy child 2. Mother having a PCL-5 score higher than > 31, 5 +/- 1 week after delivery and the traumatic event is related to childbirth or pregnancy. 3. Mother Speaking and reading French, 4. Mother with signed consent 5. Mother with rights open to social security 6. Mother and Father consent to the participation of the baby For the father: 1. holder of parental authority 2. Speaking and reading French 3. Consent to self-reported questionnaires Exclusion Criteria 1. PTSD not related to pregnancy or birth. 2. Child's health situation who impact the feasibility of the protocol, with a risk of hospitalization of more than 3 days between 6 and 12 weeks of life 3. Childbirth under 34 weeks of gestational age 4. Twins 5. Stillbirth 6. Any mother's acute, somatic or psychiatric clinical condition not compatible with the research procedure

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Interaction Guidance Therapy
Mother child psychotherapy based on video-feedback interaction after a free play session. The therapy usually enhances parent sensibility to the child.
Mother's child psychotherapeutic session
Mother's representation of the event, mother's representation of the relation to her child, maternal emotions.
Interview
History and perception of the mother's issues.
Self-rated questionnaires
Parental Self-Questionnaire to assess the perception of the evolution of the father, mother and child

Locations

Country Name City State
France CHU - Maternité Besançon
France CHU Besançon Besançon
France Centre hospitalier Intercommunal André Grégoire Montreuil
France Etablissement Ville Evrard Noisy-le-Sec
France Centre hospitalier Saint Anne Paris
France Hôpital Necker - Enfants malades - pedospychiatrie Paris
France Hôpital Necker - Maternity Paris
France Hôpital Saint Joseph - Maternité Paris
France Centre hospitalier - unité de périnalité Reims
France CHRU Reims Reims

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maternal sensitivity Evaluate by Coding Interactive Behaviour (CIB) At 4 months
Secondary Maternal sensitivity at 12 months Evaluate by Coding Interactive Behaviour (CIB) At 12 months
Secondary Prevalence of PN-PTSD Evaluate by Post-traumatic stress disorder Checklist version DSM-5 (PCL-5) At 4 months
Secondary Prevalence of PN-PTSD Evaluate by Post-traumatic stress disorder Checklist version DSM-5 (PCL-5) At 12 months
Secondary Prevalence of post natal depressive symptoms Evaluation by Edinburgh post natal depression scale (EPDS) At 4 months
Secondary Prevalence of post natal depressive symptoms Evaluation by Edinburgh post natal depression scale (EPDS) At 12 months
Secondary Infant development ASQ assessed with questionnaire fulfilled by both parents Age and Stage Questionnaire-12 (ASQ-12) Minimal score is 0 (worse) - Maximal score is >= 30 At 12 months
Secondary Infant symptoms SCL assessed with questionnaire fulfilled by both parents : Symptoms Checklist (SCL) Minimal score is 0 (worse) - Maximal score is >= 30 At 12 months
Secondary fathers' Post-traumatic stress disorder assessed with Post-traumatic stress disorder Checklist (PCL-5) Minimal score is 0 Maximal score is 80 (worse) At 4 months
Secondary fathers' Post-traumatic stress disorder assessed with Post-traumatic stress disorder Checklist (PCL-5) Minimal score is 0 Maximal score is 80 (worse) At 12 months
Secondary Father's depressive symptoms assessed with Edinburgh post natal depression scale (EPDS) Minimal score is 0 - Maximal score is 30 (worse) At 4 months
Secondary Father's depressive symptoms assessed with Edinburgh post natal depression scale (EPDS) Minimal score is 0 - Maximal score is 30 (worse) At 12 months
Secondary both parents' anxiety assessed with State Trait Anxiety Inventory (STAI) Minimal score is 20 - Maximal score is 80 (worse) At 4 months
Secondary both parents' anxiety assessed with State Trait Anxiety Inventory (STAI) Minimal score is 20 - Maximal score is 80 (worse) At 12 months
Secondary both parents' perception of social support assessed with Social Support Scale (SSQ) Minimal score is 0 (worse) - Maximal score is 54 At 4 months
Secondary both parents' perception of social support assessed with Social Support Scale (SSQ) Minimal score is 0 (worse) - Maximal score is 54 At 12 months
Secondary both parents' perception of their marital relationship assessed with Dyadic Adjustment Scale (DAS) Minimal score is 16 (worse) - Maximal score is 96 At 4 months
Secondary both parents' perception of their marital relationship assessed with Dyadic Adjustment Scale (DAS) Minimal score is 16 (worse) - Maximal score is 96 At 12 months
Secondary both parents' bonding to the child assessed with Post-partum Bonding questionnaire (PBQ). Minimal score is 0 - Maximal score is 125 (worse) At 4 months
Secondary both parents' bonding to the child assessed with Post-partum Bonding questionnaire (PBQ). Minimal score is 0 - Maximal score is 125 (worse) At 12 months
See also
  Status Clinical Trial Phase
Terminated NCT05189977 - A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline Phase 1
Completed NCT01806168 - rTMS in the Treatment of PTSD N/A
Not yet recruiting NCT06194851 - Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD Phase 2
Completed NCT02187224 - Progesterone Effect on Individuals Diagnoses With AD and PTSD. Phase 2/Phase 3
Completed NCT02549508 - Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD N/A
Completed NCT02012738 - Treatment of Trauma and Violence in the Townships of South Africa N/A
Not yet recruiting NCT01940549 - Transcranial Direct Current Stimulation (tDCS) Enhancement of Trauma-focused Therapy for Posttraumatic Stress Disorder N/A
Not yet recruiting NCT06419959 - NightWare and Cardiovascular Health in Veterans With PTSD N/A
Terminated NCT03209882 - Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Cognition in Post-traumatic Stress Disorder (PTSD) N/A
Completed NCT04891614 - The PRISM Pilot Trial for Post-Traumatic Stress Disorder N/A
Recruiting NCT05407337 - The Effect of Narrative Exposure Therapy Intervention on Post-traumatic Stress Dissorder and Personal Recovery in Refugees and Asylum Seekers of Sindiane Programme N/A
Completed NCT02030522 - Prospective Cohort Study of Accelerated Resolution Therapy (ART) for Treatment of Military Psychological Trauma N/A
Completed NCT01729325 - Prevention of Post-Traumatic Stress Disorder in Soldiers Phase 2
Completed NCT02053532 - Functional Brain Imaging in PTSD N/A
Not yet recruiting NCT02598024 - Treating Earthquake in Nepal Trauma (TENT) Trial 2016 N/A
Terminated NCT02237703 - Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD) N/A
Withdrawn NCT02356861 - LED Light Therapy to Improve Cognitive & Psychosocial Function in TBI-PTSD Veterans N/A
Not yet recruiting NCT05974631 - Evaluating Treatments for Suicidal Veterans With PTSD N/A
Not yet recruiting NCT06288594 - TraumaRelief App: A Pilot RCT Assessing Feasibility and Acceptability N/A
Completed NCT01847469 - Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence Phase 2